Farmers & Merchants Investments Inc’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-25
Closed -$2.46K 1737
2025
Q2
$2.46K Buy
25
+2
+9% +$189 ﹤0.01% 1160
2025
Q1
$2.13K Buy
23
+8
+53% +$738 ﹤0.01% 1203
2024
Q4
$1.36K Hold
15
﹤0.01% 1360
2024
Q3
$1.45K Hold
15
﹤0.01% 1339
2024
Q2
$1.38K Hold
15
﹤0.01% 1319
2024
Q1
$1.38K Hold
15
﹤0.01% 1299
2023
Q4
$1.43K Hold
15
﹤0.01% 1288
2023
Q3
$1.4K Hold
15
﹤0.01% 1226
2023
Q2
$1.37K Hold
15
﹤0.01% 1269
2023
Q1
$1.1K Hold
15
﹤0.01% 1338
2022
Q4
$1.25K Hold
15
﹤0.01% 1301
2022
Q3
$1K Buy
+15
New +$1.79K ﹤0.01% 1146
2021
Q3
Sell
-11
Closed -$3K 983
2021
Q2
$3K Buy
+11
New +$2.89K ﹤0.01% 828

Other funds holding AMED

Farmers & Merchants Investments Inc's AMED Position: Q3 2025 in Review

Farmers & Merchants Investments Inc sold out of Amedisys (AMED) in Q3 2025, closing a stake of 25 shares — an estimated $2.46K sold.

Farmers & Merchants Investments Inc first reported a position in AMED in Q2 2021 and held it in 13 quarters. The position peaked at $3K in Q2 2021. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Farmers & Merchants Investments Inc reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Farmers & Merchants Investments Inc sold 25 Amedisys shares in Q3 2025, an estimated $2.46K.
  • Farmers & Merchants Investments Inc first reported a position in Amedisys in Q2 2021 and held it in 13 quarters.
  • Farmers & Merchants Investments Inc's Amedisys position peaked at $3K in Q2 2021.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Farmers & Merchants Investments Inc's 13F filing for Q3 2025, filed 17 Oct 2025.